GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Institutional Ownership

InventisBio Co (SHSE:688382) Institutional Ownership : 15.11% (As of Apr. 27, 2025)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InventisBio Co's institutional ownership is 15.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InventisBio Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InventisBio Co's Float Percentage Of Total Shares Outstanding is 0.00%.


InventisBio Co Institutional Ownership Historical Data

The historical data trend for InventisBio Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co Institutional Ownership Chart

InventisBio Co Historical Data

The historical data trend for InventisBio Co can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 13.20 13.20 13.20 13.20 13.20 13.45 15.28 15.32 15.34 15.11

InventisBio Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


InventisBio Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines